De novo severe pemphigus vulgaris following SARS-CoV-2 vaccination with BBIBP-CorV
Dermatol Ther
.
2022 Jun;35(6):e15448.
doi: 10.1111/dth.15448.
Epub 2022 Mar 20.
Authors
Zahra Saffarian
1
2
,
Rana Samii
2
,
Alireza Ghanadan
3
,
Hassan Vahidnezhad
4
5
Affiliations
1
Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran.
2
Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
3
Department of Dermatopathology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
4
Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
5
Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
PMID:
35289040
PMCID:
PMC9111647
DOI:
10.1111/dth.15448
No abstract available
Publication types
Case Reports
Letter
MeSH terms
COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Humans
Pemphigus* / chemically induced
Pemphigus* / diagnosis
SARS-CoV-2
Vaccination / adverse effects
Substances
COVID-19 Vaccines